Immune Checkpoint Inhibitors (PD-1/PD-L1)
Unmasking cancer cells so the patient’s own T-cells can identify and destroy them.
Small Molecule Targeted Kinase Inhibitors
Directly blocking specific genetic signaling mutations (EGFR, ALK, BRAF) that drive tumor proliferation.
Explore More on OncoGuides
Browse our complete open guide directory or access the interactive tools directly on the homepage.
View All 15+ Guides